摘要
目的 分析针对性护理用于小儿肺炎支原体感染的价值。方法 对 2021 年 5 月-2022 年 5 月本
科接诊肺炎支原体感染患儿（n=60）进行随机分组，试验和对照组各 30 人，前者采取针对性护理，后者行
常规护理。对比咳嗽缓解时间等指标。结果 至于体温复常时间和咳嗽缓解时间与咳痰消失时间，试验组数
据分别是（3.31±0.93）d、（5.07±1.25）d、（4.86±1.41）d，和对照组数据（5.97±1.69）d、（7.93±1.92）d、
（7.14±1.38）d 相比更短（P＜0.05）。不良反应：试验组发生率 3.33%，和对照组数据 20.0%相比更低（P
＜0.05）。家长满意度：试验组数据 96.67%，和对照组数据 76.67%相比更高（P＜0.05）。结论 小儿肺炎
支原体感染用针对性护理，症状缓解更为迅速，不良反应发生率也更低，家长满意度改善更加明显。
关键词： 肺炎支原体感染；满意度；针对性护理；满意度
Abstract
Objective To analyze the value of targeted nursing for Mycoplasma pneumoniae infection in
children. Methods From May 2021 to May 2022, 60 children (n=60) with Mycoplasma pneumoniae infection were
randomly divided into experimental group and control group, with 30 children in each group. The former received
targeted nursing, while the latter received routine nursing. The cough relief time and other indicators were
compared. Results The temperature normalization time, cough relief time and sputum disappearance time of the
experimental group were (3.31±0.93) d, (5.07±1.25) d and (4.86±1.41) d, respectively. Compared with the control
group (5.97±1.69) d, (7.93±1.92) d, (7.14±1.38) d were shorter (P < 0.05). Adverse reactions: The incidence of the
experimental group was 3.33%, which was lower than that of the control group (20.0%) (P < 0.05). Parents'
satisfaction: 96.67% in the experimental group, which was higher than 76.67% in the control group (P < 0.05).
Conclusion Targeted nursing for Mycoplasma pneumoniae infection in children can relieve symptoms more
quickly, reduce the incidence of adverse reactions, and improve the satisfaction of parents more obviously.
Key words： Mycoplasma pneumoniae infection; Satisfaction; Targeted nursing; satisfaction
参考文献 References
[1] 甘蓓. 针对性护理在小儿肺炎支原体感染中的应用效果[J]. 国际护理学杂志,2017,36(11):1501-1503.
[2] PÍREZ,M.C., ALGORTA,G., CHAMORRO,F., et al. Changes in hospitalizations for pneumonia after universal vaccination with pneumococcal conjugate vaccines 7/13 valentand haemophilus influenzae type b conjugate vaccine in apediatric referral hospital in Uruguay[J]. The Pediatric infectious disease journal,2018,33(7):753-759.
[3] 贾文利,范君霞. 个性化护理干预在小儿肺炎支原体感染患儿中的应用效果及不良反应发生率影响观察[J].健康大视野,2018(16):143-144.
[4] HAYASHI, DAISUKE, AKASHI, YUSAKU, SUZUKI,HIROMICHI, et al. Implementation of Point-of-CareMolecular Diagnostics for Mycoplasma pneumoniaeEnsures the Correct Antimicrobial Prescription forPediatric Pneumonia Patients[J]. The Tohoku Journal ofExperimental Medicine,2018,246(4):225-231.
[5] 贾文利,范君霞. 个性化护理干预在小儿肺炎支原体感染患儿中的应用效果及不良反应发生率影响观察[J].健康大视野,2018(16):143-144.
[6] 代春苗. 针对性护理干预在小儿肺炎支原体感染中的应用价值研究[J]. 养生保健指南,2021(18):208.
[7] 陈小娘,张丽云. 针对性护理干预在小儿肺炎支原体感染中的应用价值研究[J]. 四川解剖学杂志,2021,29(1):79-80.
[8] 杨景玲. 个性化护理干预在小儿肺炎支原体感染患儿中的应用效果分析[J]. 中国医药指南,2020,18(14):257-259.
[9] 程冬兰,梁国强,邓翠碧,等. 针对性护理干预在小儿肺炎支原体感染治疗中的应用[J]. 广州医科大学学报,2019,47(2):127-129.
[10] 张爱丽. 针对性护理干预在小儿肺炎支原体感染中的应用价值研究[J]. 康颐,2022(15):43-45.